Concepedia

Thomas C. Baddeley

TC

11

Publications

400

Citations

11

H-Index

2006

Active since

Affiliations

University of Aberdeen(Current)

TauRx (United Kingdom)

Aberdeen Royal Infirmary

Douglas Mental Health University Institute

TauRx Pharmaceuticals (Singapore)

Thomas C. Baddeley is an author at University of Aberdeen specializing in organic chemistry, chemistry, and natural sciences.

Top concepts

Publications per year

2006–2022

11

Publications

11

Complex Disposition of Methylthioninium Redox Forms Determines Efficacy in Tau Aggregation Inhibitor Therapy for Alzheimer’s Disease

Thomas C. Baddeley, Jennifer McCaffrey, John M. D. Storey et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 123 citations

Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease

B. Schelter, Helen Shiells, Thomas C. Baddeley et al. · Journal of Alzheimer s Disease · 2019 · 45 citations · Full text

In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development

John Steven, Mischa Müller, Miguel F. Carvalho et al. · Frontiers in Immunology · 2017 · 44 citations · Full text

Cysteine-Independent Inhibition of Alzheimer's Disease-like Paired Helical Filament Assembly by Leuco-Methylthioninium (LMT)

Youssra K. Al‐Hilaly, Saskia J. Pollack, Janet E. Rickard et al. · Journal of Molecular Biology · 2018 · 43 citations · Full text

, , +14

Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

Helen Shiells, B. Schelter, Peter Bentham et al. · Journal of Alzheimer s Disease · 2020 · 35 citations · Full text

Rows per page

1–5 of 11